Devonian Health Group Inc.
DVHGF · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $7 | $9 |
| % Growth | 14% | -87.5% | -16.6% | – |
| Cost of Goods Sold | $1 | $0 | $5 | $6 |
| Gross Profit | $1 | $1 | $3 | $3 |
| % Margin | 50.4% | 93.5% | 36.6% | 29.6% |
| R&D Expenses | $0 | $0 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $2 | $1 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $2 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $3 | $2 |
| Operating Income | -$1 | -$0 | -$0 | $0 |
| % Margin | -108.1% | -32.4% | -0.4% | 2.7% |
| Other Income/Exp. Net | $0 | $0 | -$5 | -$0 |
| Pre-Tax Income | -$2 | -$0 | -$5 | $0 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$5 | -$0 |
| % Margin | -105.7% | -29.3% | -65.2% | -2.6% |
| EPS | -0.007 | -0.002 | -0.03 | -0.002 |
| % Growth | -272.2% | 94% | -1,900% | – |
| EPS Diluted | -0.007 | -0.002 | -0.03 | -0.002 |
| Weighted Avg Shares Out | 166 | 148 | 148 | 148 |
| Weighted Avg Shares Out Dil | 166 | 148 | 148 | 148 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$5 | $0 | $0 |
| % Margin | -102.9% | -575.7% | 0.8% | 3.8% |